Patents by Inventor Yingxun ZHANG

Yingxun ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM OF PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20240376051
    Abstract: A crystalline form of a pyrrole amide compound, a preparation method therefor and a use thereof, and also a pharmaceutical composition including the crystalline form. The crystalline form or the pharmaceutical composition can be used to treat and prevent diseases such as hyperaldosteronism, diabetic nephropathy, hypertension, heart failure (including chronic heart failure, etc.), sequelae of myocardial infarction, liver cirrhosis, renal failure, and stroke.
    Type: Application
    Filed: March 28, 2022
    Publication date: November 14, 2024
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Qiao ZONG, Liang CHEN, Yinglin ZUO, Xiaojun WANG, Jiancheng WANG, Yingxun ZHANG
  • PREPARATION METHOD FOR PYRROLE AMIDE COMPOUND
    Publication number: 20240239746
    Abstract: A preparation method for a pyrrole amide compound, as shown in formula (II). The preparation method includes: reacting a compound of formula (III) with a compound of formula (IV) in the presence of a palladium catalyst and a ligand, wherein X is Br or I; R is H, D, F, Cl, Br, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl or C1-4 haloalkoxy; and PG1 is benzyl or substituted benzyl.
    Type: Application
    Filed: April 19, 2022
    Publication date: July 18, 2024
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jiancheng WANG, Yingxun ZHANG, Chuanwen YANG, Qiao ZONG, Facheng MA, Xiaohong DING, Xiaojun WANG
  • PYRROLE AMIDE COMPOUND AND USE THEREOF
    Publication number: 20220211665
    Abstract: A pyrrole amide compound, a pharmaceutical composition thereof and use thereof. The compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.
    Type: Application
    Filed: October 21, 2020
    Publication date: July 7, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jiancheng WANG, Xiaojun WANG, Yinglin ZUO, Yingxun ZHANG, Yingjun ZHANG, Bo CHI, Wei HAN, Xiaohong DING, Junnan ZENG